NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 175 filers reported holding NEVRO CORP in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $223 | -8.6% | 6,158 | 0.0% | 0.00% | -50.0% |
Q4 2022 | $244 | -99.9% | 6,158 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $287,000 | +6.3% | 6,158 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $270,000 | -39.3% | 6,158 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $445,000 | -10.8% | 6,158 | 0.0% | 0.00% | 0.0% |
Q4 2021 | $499,000 | -30.4% | 6,158 | 0.0% | 0.00% | -50.0% |
Q3 2021 | $717,000 | -29.8% | 6,158 | 0.0% | 0.00% | -20.0% |
Q2 2021 | $1,021,000 | +25.0% | 6,158 | +5.1% | 0.01% | 0.0% |
Q1 2021 | $817,000 | -37.5% | 5,858 | -22.5% | 0.01% | -37.5% |
Q4 2020 | $1,308,000 | +24.2% | 7,558 | 0.0% | 0.01% | 0.0% |
Q3 2020 | $1,053,000 | -7.3% | 7,558 | -20.6% | 0.01% | +60.0% |
Q2 2020 | $1,136,000 | – | 9,516 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |